{"id":"methylclothiazide","rwe":[{"pmid":"10701917","year":"1999","title":"Use of ANN modelling in structure--retention relationships of diuretics in RP-HPLC.","finding":"","journal":"Journal of pharmaceutical and biomedical analysis","studyType":"Clinical Study"},{"pmid":"5163370","year":"1971","title":"Use of home-blood-pressure measurement to compare the efficacy of two diuretics. Effects of methylclothiazide and frusemide on blood pressure and plasma renin activity and electrolytes.","finding":"","journal":"The Medical journal of Australia","studyType":"Clinical Study"},{"pmid":"5790653","year":"1969","title":"[Methylclothiazide in arterial hypertension].","finding":"","journal":"Revista brasileira de medicina","studyType":"Clinical Study"},{"pmid":"5304160","year":"1968","title":"[Clinical laboratory study of essential hypertension patients treated with a methylclothiazide deserpidine combination].","finding":"","journal":"Hospital (Rio de Janeiro, Brazil)","studyType":"Clinical Study"},{"pmid":"5859341","year":"1965","title":"[Clinical trials of an antihypertensive drug, a combination of methylclothiazide and deserpidine].","finding":"","journal":"Clinique (Paris, France)","studyType":"Clinical Study"}],"tags":[{"label":"Thiazide Diuretic","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Solute carrier family 12 member 3","category":"target"},{"label":"SLC12A3","category":"gene"},{"label":"C03AA08","category":"atc"},{"label":"Active","category":"status"},{"label":"Edema","category":"indication"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Peripheral Edema due to Chronic Heart Failure","category":"indication"},{"label":"Pulmonary Edema due to Chronic Heart Failure","category":"indication"},{"label":"Renal Disease with Edema","category":"indication"},{"label":"Approved 1960s","category":"decade"},{"label":"Diuretics","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"},{"label":"Natriuretic Agents","category":"pharmacology"},{"label":"Sodium Chloride Symporter Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{"contraindications":["Acute pancreatitis","Anuria","Azotemia","Calculus in biliary tract","Chronic disease of respiratory system","Chronic heart failure","Cirrhosis of liver","Conduction disorder of the heart","Depressive disorder","Diabetes mellitus","Disease of liver","Electroconvulsive therapy","Epilepsy","Fluid volume disorder","Gout","Hypercalcemia","Hypercholesterolemia","Hypertriglyceridemia","Hyperuricemia","Hypokalemia","Hyponatremia","Impaired renal function disorder","Kidney disease","Neonatal hyperbilirubinemia","Oliguria"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=methylclothiazide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:56:59.734271+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:57:05.504114+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methylclothiazide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:57:05.896539+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Thiazide-sensitive sodium-chloride cotransporter inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:57:07.164326+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1577/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:57:06.822728+00:00"}},"allNames":"enduron","offLabel":[],"synonyms":["methychlothiazide","methylclothiazide","methyclothiazide","methyclothiazid","enduron"],"timeline":[{"date":"1960-10-21","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"approvals":[{"date":"1960-10-21","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Enduron","ecosystem":[{"indication":"Edema","otherDrugs":[{"name":"acetazolamide","slug":"acetazolamide","company":"Teva Branded Pharm"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"bumetanide","slug":"bumetanide","company":""},{"name":"chlorothiazide","slug":"chlorothiazide","company":"Oak Pharms Akorn"}],"globalPrevalence":200000},{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null},{"indication":"Peripheral Edema due to Chronic Heart Failure","otherDrugs":[{"name":"acetazolamide","slug":"acetazolamide","company":"Teva Branded Pharm"},{"name":"bumetanide","slug":"bumetanide","company":""},{"name":"chlorothiazide","slug":"chlorothiazide","company":"Oak Pharms Akorn"},{"name":"chlortalidone","slug":"chlortalidone","company":""}],"globalPrevalence":64000000},{"indication":"Pulmonary Edema due to Chronic Heart Failure","otherDrugs":[{"name":"bumetanide","slug":"bumetanide","company":""},{"name":"chlorothiazide","slug":"chlorothiazide","company":"Oak Pharms Akorn"},{"name":"chlortalidone","slug":"chlortalidone","company":""},{"name":"ethacrynic acid","slug":"ethacrynic-acid","company":"Aton"}],"globalPrevalence":64000000},{"indication":"Renal Disease with Edema","otherDrugs":[{"name":"bumetanide","slug":"bumetanide","company":""},{"name":"metolazone","slug":"metolazone","company":"Ucb Inc"},{"name":"torsemide","slug":"torsemide","company":"Meda Pharms"}],"globalPrevalence":null}],"mechanism":{"target":"Solute carrier family 12 member 3","novelty":"Follow-on","targets":[{"gene":"SLC12A3","source":"DrugCentral","target":"Solute carrier family 12 member 3","protein":"Solute carrier family 12 member 3"}],"modality":"Small Molecule","drugClass":"Thiazide Diuretic","explanation":"","oneSentence":"","technicalDetail":"Enduron acts as a competitive inhibitor of the sodium-chloride cotransporter (NCC) in the distal convoluted tubule of the kidneys, reducing sodium reabsorption and increasing sodium excretion, which leads to increased urine production and decreased blood volume."},"commercial":{"launchDate":"1960","_launchSource":"DrugCentral (FDA 1960-10-21, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1759","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methylclothiazide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:39:22.725295","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:57:08.391102+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"bendroflumethiazide","drugSlug":"bendroflumethiazide","fdaApproval":"1959-12-07","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"hydroflumethiazide","drugSlug":"hydroflumethiazide","fdaApproval":"1959-07-22","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"hydrochlorothiazide","drugSlug":"hydrochlorothiazide","fdaApproval":"1959-02-12","patentExpiry":"Jan 23, 2044","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"chlorothiazide","drugSlug":"chlorothiazide","fdaApproval":"1958-09-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"polythiazide","drugSlug":"polythiazide","fdaApproval":"1961-09-26","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"trichlormethiazide","drugSlug":"trichlormethiazide","fdaApproval":"1960-03-09","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cyclothiazide","drugSlug":"cyclothiazide","fdaApproval":"1982-06-08","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"methylclothiazide","indications":{"approved":[{"name":"Edema","source":"DrugCentral","snomedId":267038008,"regulator":"FDA","usPrevalence":null,"globalPrevalence":200000,"prevalenceMethod":"curated","prevalenceSource":"Int Arch Allergy Immunol, 2025 (PMID:39827848)"},{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"},{"name":"Peripheral Edema due to Chronic Heart Failure","source":"DrugCentral","snomedId":"","regulator":"FDA","usPrevalence":6200000,"globalPrevalence":64000000,"prevalenceMethod":"curated","prevalenceSource":"ESC Heart Failure, 2023"},{"name":"Pulmonary Edema due to Chronic Heart Failure","source":"DrugCentral","snomedId":"","regulator":"FDA","usPrevalence":6200000,"globalPrevalence":64000000,"prevalenceMethod":"curated","prevalenceSource":"ESC Heart Failure, 2023"},{"name":"Renal Disease with Edema","source":"DrugCentral","snomedId":"","regulator":"FDA"}],"offLabel":[{"name":"Calcium renal calculus","source":"DrugCentral","drugName":"methylclothiazide","evidenceCount":0,"evidenceLevel":"emerging"},{"name":"Diabetes insipidus","source":"DrugCentral","drugName":"methylclothiazide","evidenceCount":0,"evidenceLevel":"emerging"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"bendroflumethiazide","brandName":"bendroflumethiazide","genericName":"bendroflumethiazide","approvalYear":"1959","relationship":"same-class"},{"drugId":"hydroflumethiazide","brandName":"hydroflumethiazide","genericName":"hydroflumethiazide","approvalYear":"1959","relationship":"same-class"},{"drugId":"hydrochlorothiazide","brandName":"hydrochlorothiazide","genericName":"hydrochlorothiazide","approvalYear":"1959","relationship":"same-class"},{"drugId":"chlorothiazide","brandName":"chlorothiazide","genericName":"chlorothiazide","approvalYear":"1958","relationship":"same-class"},{"drugId":"polythiazide","brandName":"polythiazide","genericName":"polythiazide","approvalYear":"1961","relationship":"same-class"},{"drugId":"trichlormethiazide","brandName":"trichlormethiazide","genericName":"trichlormethiazide","approvalYear":"1960","relationship":"same-class"},{"drugId":"cyclothiazide","brandName":"cyclothiazide","genericName":"cyclothiazide","approvalYear":"1982","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000146766","MMSL":"1033","NDDF":"002301","UNII":"L3H46UAC61","VUID":"4018442","CHEBI":"CHEBI:6847","VANDF":"4018442","INN_ID":"1050","RXNORM":"224934","UMLSCUI":"C0025696","chemblId":"CHEMBL1577","ChEMBL_ID":"CHEMBL1577","KEGG_DRUG":"D00656","DRUGBANK_ID":"DB00232","PUBCHEM_CID":"4121","SNOMEDCT_US":"387373008","IUPHAR_LIGAND_ID":"7235","MESH_DESCRIPTOR_UI":"D008736"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C03AA08","allCodes":["C03AA08","C03AB08"]},"biosimilarFilings":[],"recentPublications":[{"date":"1999 Oct","pmid":"10701917","title":"Use of ANN modelling in structure--retention relationships of diuretics in RP-HPLC.","journal":"Journal of pharmaceutical and biomedical analysis"},{"date":"1971 Sep 11","pmid":"5163370","title":"Use of home-blood-pressure measurement to compare the efficacy of two diuretics. Effects of methylclothiazide and frusemide on blood pressure and plasma renin activity and electrolytes.","journal":"The Medical journal of Australia"},{"date":"1969 Feb","pmid":"5790653","title":"[Methylclothiazide in arterial hypertension].","journal":"Revista brasileira de medicina"},{"date":"1968 Oct","pmid":"5304160","title":"[Clinical laboratory study of essential hypertension patients treated with a methylclothiazide deserpidine combination].","journal":"Hospital (Rio de Janeiro, Brazil)"},{"date":"1965 Nov","pmid":"5859341","title":"[Clinical trials of an antihypertensive drug, a combination of methylclothiazide and deserpidine].","journal":"Clinique (Paris, France)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"1960","aiSummary":"Enduron is a small molecule that inhibits the thiazide-sensitive sodium-chloride cotransporter, and it has been studied in clinical trials for various conditions including osteoarthritis, post-traumatic arthritis, and avascular necrosis.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1960-10-21T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:57:08.391102+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}